fbpx Legislation gaining momentum as changes to Contact Lens Rule take effect | Johnson & Johnson Vision Legislation gaining momentum as changes to Contact Lens Rule take effect | Johnson & Johnson Vision Skip to main content

Legislation gaining momentum as changes to Contact Lens Rule take effect

Dear Eye Health Advocates:

On October 16, 2020, major updates to the Federal Trade Commission (FTC) Contact Lens Rule (CLR) will take effect for both contact lens prescribers and sellers. Please know we are here to support you. We understand these new updates bring significant administrative implications, and that’s why Johnson & Johnson Vision developed a comprehensive resource to help you understand what the updates mean and actions you’ll need to take. Additionally we’ve included another resource, created by the American Optometric Association, which you can access here.

As you know, the Final Rule missed a critical opportunity to modernize the prescription verification process by eliminating robocalls, and instead added substantially more complexity and paperwork to the prescription release process. We empathize with you as an eye care professional who is impacted by these new requirements—and we are committed to continue working by your side to lead the industry in advocacy efforts for you and your patients.

It’s clear to us that eye health is more important today than ever before, and that we must continue to join forces to support you as an eye care provider. This is why Johnson & Johnson Vision is currently leading and supporting several actions in the United States (U.S.) Congress to address important eye health issues that impact your practice and patients, including our support for eliminating robocalls and rolling back the administrative burden imposed in the CLR. These efforts include, but are not limited to:

  1. We backed new legislation in the U.S. Senate to not only get rid of robocalls, but remove burdensome ‘signed acknowledgement’ prescription release requirements—replacing paperwork with posted signage so you can focus on patient care, not added administration. 
  2. We applaud a request by the Congressional Appropriations Committee to the FTC to delay the new requirements in the CLR—to give you more time to prepare.
  3. We supported legislation in the U.S. House of Representatives to eliminate robocalls as a permissible form of verification for sellers—to free up your phone lines and promote a better “paper trail” for verification to encourage a more error-free prescription fulfillment so that your patients don’t receive the wrong lenses because of passive verification.

As we move forward, we will also provide simple and effective ways you can also directly engage in these efforts to address the missed opportunities in the CLR.

We’ve been there for you before, we remain here with you today, and we will continue to work by your side to emerge stronger than ever before, together.

In the meantime, spread the word by sharing this update with a friend or colleague.


Mike Mayers, O.D., FAAO
Director, US Advocacy
Johnson & Johnson Vision Care, Inc.

Thomas Swinnen
President, North America
Johnson & Johnson Vision Care, Inc.